|
Afayibo D
J A, Zhu H, Zhang B, Yao L, Abdelgawad H A, Tian M, Qi J, Liu Y, Wang S. 2022.
Isolation, molecular characterization, and antibiotic resistance of avian
pathogenic Escherichia coli in Eastern China. Veterinary Sciences, 9, 319.
Aldawood
E, Roberts I S. 2022. Regulation of Escherichia coli group 2
capsule gene expression: A mini review and update. Frontiers in Microbiology, 13, 858767.
Ares M A,
Fernández-Vázquez J L, Rosales-Reyes R, Jarillo-Quijada M D, von Bargen K,
Torres J, González-y-Merchand J A, Alcántar-Curiel M D, De la Cruz M A. 2016.
H-NS nucleoid protein controls virulence features of Klebsiella pneumoniae by
regulating the expression of type 3 pili and the capsule polysaccharide. Frontiers in Cellular and Infection Microbiology, 6,
13.
Arshad M,
Beggs G A, Brennan R G, Seed P C. 2020. Optimization of a noncanonical
anti-infective: Interrogation of the target binding pocket for a small-molecule
inhibitor of Escherichia coli polysaccharide capsule expression. Antimicrobial Agents and Chemotherapy, 65, e01208–e01228.
Audia J P,
Webb C C, Foster J W. 2001. Breaking through the acid barrier: An orchestrated
response to proton stress by enteric bacteria. International Journal of Medical Microbiology, 291, 97–106.
Balasubramanian
D, Kumari H, Jaric M, Fernandez M, Turner K H, Dove S L, Narasimhan G, Lory S,
Mathee K. 2013. Deep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat
shock and oxidative stress response. Nucleic Acids Research, 42, 979–998.
Baldi D L,
Higginson E E, Hocking D M, Praszkier J, Cavaliere R, James C E, Bennett-Wood
V, Azzopardi K I, Turnbull L, Lithgow T, Robins-Browne R M, Whitchurch C B,
Tauschek M. 2012. The type II secretion system and its ubiquitous lipoprotein
substrate, SslE, are required for biofilm formation and virulence of
enteropathogenic Escherichia coli. Infection and Immunity, 80, 2042–2052.
Barrangou
R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero D A, Horvath
P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science, 315, 1709–1712.
Boon N,
Kaur M, Aziz A, Bradnick M, Shibayama K, Eguchi Y, Lund P A. 2020. The
signaling molecule indole inhibits induction of the AR2 acid resistance system
in Escherichia coli. Frontiers in Microbiology, 11, 474.
Brede C M,
Shoskes D A. 2011. The etiology and management of acute prostatitis. Nature Reviews Urology, 8, 207–212.
Brooun A,
Tomashek J J, Lewis K. 1999. Purification and ligand binding of EmrR, a
regulator of a multidrug transporter. Journal of Bacteriology, 181, 5131–5133.
Brouns S
J, Jore M M, Lundgren M, Westra E R, Slijkhuis R J, Snijders A P, Dickman M J,
Makarova K S, Koonin E V, van der Oost J. 2008. Small CRISPR RNAs guide
antiviral defense in prokaryotes. Science, 321, 960–964.
Burton N
A, Johnson M D, Antczak P, Robinson A, Lund P A. 2010. Novel aspects of the
acid response network of E. coli K-12 are revealed by a study of
transcriptional dynamics. Journal of Molecular Biology, 401, 726–742.
Chen Y H,
Hsueh P R. 2012. Changing bacteriology of abdominal and surgical sepsis. Current Opinion in Infectious Diseases, 25, 590–595.
Cherepanov
P P, Wackernagel W. 1995. Gene disruption in Escherichia coli:
TcR and KmR cassettes with the option of Flp-catalyzed excision of the
antibiotic-resistance determinant. Gene, 158, 9–14.
Corbett D,
Hudson T, Roberts I S. 2010. Bacterial polysaccharide capsules. Prokaryotic Cell Wall Compounds (Structure and Biochemistry), 2010,
111–132.
Dale A P,
Woodford N. 2015. Extra-intestinal pathogenic Escherichia coli (ExPEC): Disease, carriage and clones. Journal of Infection, 71, 615–626.
Datsenko K
A, Wanner B L. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proceedings of the National Academy of Sciences of the United States of America, 97,
6640–6645.
Eguchi Y,
Utsumi R. 2014. Alkali metals in addition to acidic pH activate the EvgS
histidine kinase sensor in Escherichia coli. Journal of Bacteriology, 196, 3140–3149.
Foxman B,
Brown P. 2003. Epidemiology of urinary tract infections: Transmission and risk
factors, incidence, and costs. Infectious Disease Clinics of North America, 17, 227–241.
Goh K G,
Phan M D, Forde B M, Chong T M, Yin W F, Chan K G, Ulett G C, Sweet M J,
Beatson S A, Schembri M A. 2017. Genome-wide discovery of genes required for
capsule production by uropathogenic Escherichia coli. mBio, 8, e01558-e01575.
Goller C
C, Arshad M, Noah J W, Ananthan S, Evans C W, Nebane N M, Rasmussen L, Sosa M,
Tower N A, White E L, Neuenswander B, Porubsky P, Maki B E, Rogers S A,
Schoenen F, Seed P C. 2014. Lifting the mask: Identification of new small
molecule inhibitors of uropathogenic Escherichia coli group 2
capsule biogenesis. PLoS ONE, 9, e96054.
Goller C
C, Seed P C. 2010. High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents. PLoS ONE, 5, e11642.
Gu H, Cai
X, Zhang X, Luo J, Zhang X, Hu X, Cai W, Li G. 2021. A previously
uncharacterized two-component signaling system in uropathogenic Escherichia coli coordinates protection against host-derived oxidative stress with
activation of hemolysin-mediated host cell pyroptosis. Plos Pathogens, 17, e1010005.
Gu S,
Shevchik V E, Shaw R, Pickersgill R W, Garnett J A. 2017. The role of intrinsic
disorder and dynamics in the assembly and function of the type II secretion
system. Biochimica et Biophysica Acta (BBA)
(Proteins and Proteomics), 1865, 1255–1266.
Hu J,
Afayibo D J A, Zhang B, Zhu H, Yao L, Guo W, Wang X, Wang Z, Wang D, Peng H,
Tian M, Qi J, Wang S. 2022. Characteristics, pathogenic mechanism, zoonotic
potential, drug resistance, and prevention of avian pathogenic Escherichia coli (APEC). Frontiers in Microbiology, 13,
1049391.
Iguchi A,
Thomson N R, Ogura Y, Saunders D, Ooka T, Henderson I R, Harris D, Asadulghani
M, Kurokawa K, Dean P, Kenny B, Quail M A, Thurston S, Dougan G, Hayashi T,
Parkhill J, Frankel G. 2009. Complete genome sequence and comparative genome
analysis of enteropathogenic Escherichia coli O127: H6 strain
E2348/69. Journal of Bacteriology, 191, 347–354.
Itou J,
Eguchi Y, Utsumi R. 2009. Molecular mechanism of transcriptional cascade
initiated by the EvgS/EvgA system in Escherichia coli K-12. Bioscience, Biotechnology, and Biochemistry, 73, 870–878.
Jeong J,
Lee J Y, Kang M S, Lee H J, Kang S I, Lee O M, Kwon Y K, Kim J H. 2021.
Comparative characteristics and zoonotic potential of avian pathogenic Escherichia coli (APEC) isolates from chicken and duck in South Korea. Microorganisms, 9, 946.
Kaper J B,
Nataro J P, Mobley H L. 2004. Pathogenic Escherichia coli. Nature Reviews Microbiology, 2, 123–140.
Karthik L,
Kumar G, Keswani T, Bhattacharyya A, Chandar S S, Bhaskara Rao K V. 2014.
Protease inhibitors from marine actinobacteria as a potential source for
antimalarial compound. PLoS ONE, 9, e90972.
Kato A,
Ohnishi H, Yamamoto K, Furuta E, Tanabe H, Utsumi R. 2000. Transcription of emrKY is regulated by the EvgA-EvgS two-component system in Escherichia coli K-12. Bioscience, Biotechnology, and Biochemistry, 64,
1203–1209.
Kim K S.
2003. Pathogenesis of bacterial meningitis: From bacteraemia to neuronal
injury. Nature Reviews Neuroscience, 4, 376–385.
Köhler C
D, Dobrindt U. 2011. What defines extraintestinal pathogenic Escherichia coli? International Journal of Medical Microbiology, 301, 642–647.
Li G,
Ewers C, Laturnus C, Diehl I, Alt K, Dai J, Antão E M, Schnetz K, Wieler L H.
2008. Characterization of a yjjQ mutant of avian pathogenic Escherichia coli (APEC). Microbiology, 154, 1082–1093.
Li G,
Tivendale K A, Liu P, Feng Y, Wannemuehler Y, Cai W, Mangiamele P, Johnson T J,
Constantinidou C, Penn C W, Nolan L K. 2011. Transcriptome analysis of avian
pathogenic Escherichia coli O1 in chicken serum reveals adaptive
responses to systemic infection. Infection and Immunity, 79,
1951–1960.
Li H,
Durbin R. 2010. Fast and accurate long-read alignment with Burrows–Wheeler
transform. Bioinformatics, 26, 589–595.
Li H, Hu
S, Yan X, Yang Y, Liu W, Bu Z, Li G, Cai W. 2021. An extracytoplasmic function
(ECF) sigma/anti-sigma factor system regulates hypochlorous acid resistance and
impacts expression of the type IV secretion system in Brucella melitensis. Journal of Bacteriology, 203, e0012721.
Li N, Wei
S, Chen J, Yang F, Kong L, Chen C, Ding X, Chu Z. 2018. OsASR 2 regulates the
expression of a defence-related gene, Os2H16, by targeting the GT-1
cis-element. Plant Biotechnology Journal, 16,
771–783.
Ma J, An
C, Jiang F, Yao H, Logue C, Nolan L K, Li G. 2018. Extraintestinal pathogenic Escherichia coli increase extracytoplasmic polysaccharide biosynthesis for serum
resistance in response to bloodstream signals. Molecular Microbiology, 110, 689–706.
Ma J, Bao
Y, Sun M, Dong W, Pan Z, Zhang W, Lu C, Yao H. 2014. Two functional type VI
secretion systems in avian pathogenic Escherichia coli are
involved in different pathogenic pathways. Infection and Immunity, 82, 3867–3879.
Masuda N,
Church G M. 2002. Escherichia coli gene expression responsive to
levels of the response regulator EvgA. Journal of Bacteriology, 184, 6225–6234.
Mobley H
L, Green D M, Trifillis A L, Johnson D E, Chippendale G R, Lockatell C V, Jones
B D, Warren J W. 1990. Pyelonephritogenic Escherichia coli and
killing of cultured human renal proximal tubular epithelial cells: Role of
hemolysin in some strains. Infection and Immunity, 58,
1281–1289.
Moriel D
G, Tan L, Goh K G, Phan M D, Ipe D S, Lo A W, Peters K M, Ulett G C, Beatson S
A, Schembri M A. 2016. A novel protective vaccine antigen from the core Escherichia coli genome. mSphere, 1, e00326–e00342.
Mulvey M
A, Schilling J D, Hultgren S J. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infection and Immunity, 69, 4572–4579.
Nesta B,
Valeri M, Spagnuolo A, Rosini R, Mora M, Donato P, Alteri C J, Del Vecchio M,
Buccato S, Pezzicoli A, Bertoldi I, Buzzigoli L, Tuscano G, Falduto M, Rippa V,
Ashhab Y, Bensi G, Fontana M R, Seib K L, Mobley H L, et al. 2014.
SslE elicits functional antibodies that impair in vitro mucinase
activity and in vivo colonization by both intestinal and
extraintestinal Escherichia coli strains. PLoS Pathogens, 10, e1004124.
Palaniappan
R U, Zhang Y, Chiu D, Torres A, Debroy C, Whittam T S, Chang Y F. 2006.
Differentiation of Escherichia coli pathotypes by oligonucleotide
spotted array. Journal of Clinical Microbiology, 44,
1495–1501.
Pfaffl M
W. 2001. A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Research, 29, e45.
Pitout J
D. 2012. Extraintestinal pathogenic Escherichia coli: A
combination of virulence with antibiotic resistance. Frontiers in Microbiology, 3, 9.
Ranfaing
J, Dunyach-Remy C, Lavigne J P, Sotto A. 2018. Propolis potentiates the effect
of cranberry (Vaccinium macrocarpon) in reducing the motility and
the biofilm formation of uropathogenic Escherichia coli. PLoS ONE, 13, e0202609.
Rodionov D
A, Gelfand M S, Mironov A A, Rakhmaninova A B. 2001. Comparative approach to
analysis of regulation in complete genomes: Multidrug resistance systems in
gamma-proteobacteria. Journal of Molecular Microbiology and Biotechnology, 3, 319–324.
Ronco T,
Stegger M, Olsen R H, Sekse C, Nordstoga A B, Pohjanvirta T, Lilje B, Lyhs U,
Andersen P S, Pedersen K. 2017. Spread of avian pathogenic Escherichia coli ST117 O78:H4 in Nordic broiler production. BMC Genomics, 18,
13.
Russell D
W, Sambrook J. 2001. Molecular Cloning: A Laboratory Manual. Cold Spring
Harbor Laboratory Cold Spring Harbor, NY.
Sharma H,
Tal R, Clark N A, Segars J H. 2014. Microbiota and pelvic inflammatory disease. Seminars in Reproductive Medicine, 32, 43–49.
Sheehan L
M, Budnick J A, Fyffe-Blair J, King K A, Settlage R E, Caswell C C. 2020. The
endoribonuclease RNase E coordinates expression of mRNAs and small regulatory
RNAs and is critical for the virulence of Brucella abortus. Journal of Bacteriology, 202, e00240–e00260.
Silver R
P, Aaronson W, Sutton A, Schneerson R. 1980. Comparative analysis of plasmids
and some metabolic characteristics of Escherichia coli K1 from
diseased and healthy individuals. Infection and Immunity, 29,
200–206.
Strozen T
G, Li G, Howard S P. 2012. YghG (GspSβ) is a novel pilot protein required for
localization of the GspSβ type II secretion system secretin of enterotoxigenic Escherichia coli. Infection and Immunity, 80, 2608–2622.
Talan D A,
Stamm W E, Hooton T M, Moran G J, Burke T, Iravani A, Reuning-Scherer J, Church
D A. 2000. Comparison of ciprofloxacin (7 days) and
trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis
in women: A randomized trial. The Journal of American Medical Association, 283, 1583–1590.
Tapader R,
Bose D, Dutta P, Das S, Pal A. 2018. SslE (YghJ), a cell-associated and
secreted lipoprotein of neonatal septicemic Escherichia coli,
Induces toll-like receptor 2-dependent macrophage activation and
proinflammation through NF-κB and MAP kinase signaling. Infection and Immunity, 86, e00399–e00417.
Teng C H,
Cai M, Shin S, Xie Y, Kim K J, Khan N A, Di Cello F, Kim K S. 2005. Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state. Infection and Immunity, 73, 2923–2931.
Weiss-Muszkat
M, Shakh D, Zhou Y, Pinto R, Belausov E, Chapman M R, Sela S. 2010. Biofilm
formation by and multicellular behavior of Escherichia coli O55:H7, an atypical enteropathogenic strain. Applied and Environmental Microbiology, 76, 1545–1554.
Westra E
R, Pul Ü, Heidrich N, Jore M M, Lundgren M, Stratmann T, Wurm R, Raine A,
Mescher M, Van Heereveld L. 2010. H-NS-mediated repression of CRISPR-based
immunity in Escherichia coli K12 can be relieved by the
transcription activator LeuO. Molecular Microbiology, 77,
1380–1393.
Whitfield
C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annual Review of Biochemistry, 75,
39–68.
Wiles T J,
Kulesus R R, Mulvey M A. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Experimental and Molecular Pathology, 85, 11–19.
Xiong A,
Gottman A, Park C, Baetens M, Pandza S, Matin A. 2000. The EmrR protein
represses the Escherichia coli emrRAB multidrug resistance
operon by directly binding to its promoter region. Antimicrobial Agents and Chemotherapy, 44, 2905–2907.
Xu Q, Yang
X, Chan E W C, Chen S. 2021. The hypermucoviscosity of hypervirulent K. pneumoniae confers the ability to evade neutrophil-mediated phagocytosis. Virulence, 12, 2050–2059.
Xue C,
Sashital D G. 2019. Mechanisms of type IE and IF CRISPR-Cas systems in Enterobacteriaceae. EcoSal Plus, 8, doi: 10.1128/ecosalplus.ESP-0008-2018.
Yang D,
Kong Y, Sun W, Kong W, Shi Y. 2019. A dopamine-responsive signal transduction
controls transcription of Salmonella enterica Serovar Typhimurium
virulence genes. mBio, 10, e02772–e02790.
Yang J,
Baldi D L, Tauschek M, Strugnell R, ARobins-Browne R M. 2007. Transcriptional
regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM cluster, encoding the
type II secretion pathway in enterotoxigenic Escherichia coli. Journal of Bacteriology, 189, 142–150.
Zhang H,
Chen X, Nolan L K, Zhang W, Li G. 2019. Identification of host adaptation genes
in extraintestinal pathogenic Escherichia coli during infection
in different hosts. Infection and Immunity, 87,
e00666–e00685.
Zhuge X,
Wang S, Fan H, Pan Z, Ren J, Yi L, Meng Q, Yang X, Lu C, Dai J. 2013.
Characterization and functional analysis of AatB, a novel autotransporter
adhesin and virulence factor of avian pathogenic Escherichia coli. Infection and Immunity, 81, 2437–2447.
|
